PT  - JOURNAL ARTICLE
AU  - Brown, Rebekah E.
AU  - Noah, Akaninyene I.
AU  - Hill, Ashley V.
AU  - Taylor, Brandie DePaoli
TI  - Fetal sexual dimorphism and preeclampsia among twin pregnancies
AID  - 10.1101/2023.11.10.23298403
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.11.10.23298403
4099  - http://medrxiv.org/content/early/2023/11/11/2023.11.10.23298403.short
4100  - http://medrxiv.org/content/early/2023/11/11/2023.11.10.23298403.full
AB  - Background In singleton pregnancies, fetal sexual dimorphism has been observed in hypertensive disorders of pregnancy (HDP), particularly preeclampsia, a morbid syndrome that increases risk of adult onset cardiovascular disease for mothers and their offspring. However, few studies have explored the effect of fetal sex on HDP among twin pregnancies.Methods We conducted a retrospective cohort study of 1,032 twin pregnancies between 2011 - 2022 using data from a perinatal database that recruits participants from three hospitals in Houston, TX. We categorized pregnancies based on fetal sex pairings into female/female, male/male, and female/male. Pregnancies with a female/female fetal sex were used as our reference group. Our primary outcomes included gestational hypertension, preeclampsia, superimposed preeclampsia, and preeclampsia subtyped by gestational age of delivery. A modified Poisson regression model with robust error variance was used to calculate the relative risk (RR) and 95% confidence interval (CI) for the association between fetal sex pairs and HDP.Results Adjusted models of female/male fetal sex pairs were associated with preterm preeclampsia (RR 2.01, 95% CI 1.15-3.53) relative to those with female/female fetuses. No associations with other HDP were observed among pregnancies with male/male fetal sex compared to those with female/female fetal sex pairs.Conclusions We found some evidence of sexual dimorphism for preterm preeclampsia among female/male twin pairs. Additional research is needed to understand what biological mechanisms could explain these findings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research is funded in part by the National Institutes of Allergy and Infectious Diseases (NIAID) grant 1RO1AI141501-O1A1 to B.D.T. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board (IRB) at the University of Texas Medical Branch.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Not ApplicableThe data used in this manuscript was provided by Peribank under license/permission. Access to data requires permission from Peribank